NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Neuroone Medical Technologies's ebitda for the twelve months ending Jun 30, 2026 was -$7.66M. For fiscal 2025 it was -$3.96M. The highest annual figure on record is -$3.96M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$3.96M | – |
| FY2024 | Sep 30, 2024 | -$11.64M | – |
| FY2023 | Sep 30, 2023 | -$11.76M | – |
| FY2022 | Sep 30, 2022 | -$9.91M | – |
| FY2021 | Sep 30, 2021 | -$10.14M | – |
| FY2020 | Sep 30, 2020 | -$4.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$2.38M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$2.34M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$1.64M | -192.4% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$1.31M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.82M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$2.61M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.78M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$2.75M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$2.73M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$2.83M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$3.33M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$3.10M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$3.45M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$3.45M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$1.75M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$1.37M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.73M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$3.03M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$2.78M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$2.62M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$3.01M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.38M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$2.12M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$103.66K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.58M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.37M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$1.80M | – |
See a number that looks wrong?